稲熊 大城

Medicine & Life Sciences

1. Dialysis 100%
2. Chronic Renal Insufficiency 65%
3. Cohort Studies 42%
4. Mortality 41%
5. Kidney 33%
6. Prospective Studies 29%
7. Antineutrophil Cytoplasmic Antibodies 27%
8. Serum 24%
9. Japan 23%
10. Glomerular Filtration Rate 22%
11. continuous erythropoietin receptor activator 22%
12. Renal Dialysis 19%
13. Vasculitis 19%
14. Calcitriol Receptors 19%
15. Chronic Kidney Failure 19%
16. Hemoglobins 15%
17. Kidney Transplantation 13%
18. Creatinine 12%
19. Cardiovascular Diseases 12%
20. Maintenance 11%
21. Multicenter Studies 11%
22. Diet Therapy 10%
23. alfacalcidol 10%
24. Peritoneal Dialysis 10%
25. Secondary Hyperparathyroidism 10%
26. Biopsy 10%
27. Incidence 9%
28. Glomerulonephritis 9%
29. Immunoglobulin A 9%
30. Anemia 9%
31. Observational Studies 8%
32. Vitamin D 8%
33. Confidence Intervals 8%
34. Parathyroid Hormone 8%
35. Therapeutics 8%
36. 1,25-dihydroxyvitamin D 8%
37. Nephrologists 8%
38. Renin-Angiotensin System 7%
39. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 7%
40. Blood Component Removal 7%
41. Transplants 7%
42. Antibodies 7%
43. Peroxidase 7%
44. Recurrence 6%
45. Aortic Valve Stenosis 6%
46. Sleep Apnea Syndromes 6%
47. Erythropoietin 6%
48. Calcium 6%
49. Diabetic Nephropathies 6%
50. Glomerulopathy with fibronectin deposits 6%